Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- PrandiMet
Descriptions
Repaglinide and metformin combination is used to treat high blood sugar levels caused by a type of diabetes mellitus (sugar diabetes) called type 2 diabetes. It is used together with a proper diet and exercise to help control blood sugar levels in patients who are already treated with meglitinide and metformin combination, or in patients who have been taking meglitinide or metformin but did not work well.
Repaglinide causes your pancreas to release more insulin into the blood stream. Metformin reduces the absorption of sugar from the stomach, reduces the release of stored sugar from the liver, and helps your body use sugar better.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Jan. 01, 2021
Copyright © 2021 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.